Aleksandar Dakic
Aleksandar Dakic
Melbourne Integrative Genomics, University of Melbourne
Verified email at unimelb.edu.au
TitleCited byYear
Tumor growth need not be driven by rare cancer stem cells
PN Kelly, A Dakic, JM Adams, SL Nutt, A Strasser
Science 317 (5836), 337-337, 2007
9202007
Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo
SH Naik, P Sathe, HY Park, D Metcalf, AI Proietto, A Dakic, S Carotta, ...
Nature immunology 8 (11), 1217, 2007
7102007
Cutting edge: generation of splenic CD8+ and CD8− dendritic cell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures
SH Naik, AI Proietto, NS Wilson, A Dakic, P Schnorrer, M Fuchsberger, ...
The Journal of Immunology 174 (11), 6592-6597, 2005
4692005
PU. 1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis
A Dakic, D Metcalf, L Di Rago, S Mifsud, L Wu, SL Nutt
Journal of Experimental Medicine 201 (9), 1487-1502, 2005
2822005
The transcription factor PU. 1 controls dendritic cell development and Flt3 cytokine receptor expression in a dose-dependent manner
S Carotta, A Dakic, A D'amico, SHM Pang, KT Greig, SL Nutt, L Wu
Immunity 32 (5), 628-641, 2010
2302010
Response to comment on" tumor growth need not be driven by rare cancer stem cells"
JM Adams, PN Kelly, A Dakic, SL Nutt, A Strasser
Science 318 (5857), 1722-1722, 2007
1482007
Development of the dendritic cell system during mouse ontogeny
A Dakic, Q Shao, A D’Amico, M O’Keeffe, W Chen, K Shortman, L Wu
The Journal of Immunology 172 (2), 1018-1027, 2004
1452004
Stage-specific control of early B cell development by the transcription factor Ikaros
TA Schwickert, H Tagoh, S Gültekin, A Dakic, E Axelsson, M Minnich, ...
Nature immunology 15 (3), 283, 2014
1362014
Identification of Pax5 target genes in early B cell differentiation
C Pridans, ML Holmes, M Polli, JM Wettenhall, A Dakic, LM Corcoran, ...
The Journal of Immunology 180 (3), 1719-1728, 2008
1152008
Development of dendritic cell system
L Wu, A Dakic
Cell Mol Immunol 1 (2), 112-8, 2004
1152004
Inactivation of PU. 1 in adult mice leads to the development of myeloid leukemia
D Metcalf, A Dakic, S Mifsud, L Di Rago, L Wu, S Nutt
Proceedings of the National Academy of Sciences 103 (5), 1486-1491, 2006
992006
The development of functional B lymphocytes in conditional PU. 1 knock-out mice
M Polli, A Dakic, A Light, L Wu, DM Tarlinton, SL Nutt
Blood 106 (6), 2083-2090, 2005
852005
Is PU. 1 a dosage-sensitive regulator of haemopoietic lineage commitment and leukaemogenesis?
A Dakic, L Wu, SL Nutt
Trends in immunology 28 (3), 108-114, 2007
712007
Role of “cancer stem cells” and cell survival in tumor development and maintenance
JM Adams, PN Kelly, A Dakic, S Carotta, SL Nutt, A Strasser
Cold Spring Harbor symposia on quantitative biology 73, 451-459, 2008
352008
Hemopoietic precursors and development of dendritic cell populations
A Dakic, L Wu
Leukemia & lymphoma 44 (9), 1469-1475, 2003
312003
The Pu. 1 target gene Zbtb11 regulates neutrophil development through its integrase-like HHCC zinc finger
MC Keightley, DP Carradice, JE Layton, L Pase, JY Bertrand, JG Wittig, ...
Nature Communications 8, 14911, 2017
52017
Development of Dendritic Cell System
A Dakic
Cellular & Molecular Immunology, 4, 2004
22004
Interconversion between tumorigenic and differentiated states in acute myeloid leukemia
MD McKenzie, M Ghisi, EP Oxley, S Ngo, L Cimmino, C Esnault, R Liu, ...
Cell Stem Cell 25 (2), 258-272. e9, 2019
12019
Excess granulopoiesis and subsequent acute myeloid leukemia induced by complete loss of PU. 1 in adult mice
A Dakic, D Metcalf, L Di Rago, S Mifsud, L Wu, SL Nutt
Tissue Antigens 66 (5), 388-389, 2005
12005
The Transcription Factor PU. 1 Controls a Reversible Differentiation Program in Acute Myeloid Leukemia
MD McKenzie, M Ghisi, L Cimmino, M Erlichster, EP Oxley, C Liu, ...
Blood 128 (22), 3930-3930, 2016
2016
The system can't perform the operation now. Try again later.
Articles 1–20